EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity

Simon R Green iD, Caroline Wilson, Thomas C Eadsforth, Avinash S Punekar, Fabio K Tamaki, Gavin Wood, Nicola Caldwell iD, Barbara Forte iD, Neil R Norcross, Michael Kiczun, John M Post, Eva Maria Lopez-Román und 11 weitere

Journal of Medicinal Chemistry · 23.11.2023 · 66 (22) · 15380-15408

DOI: 10.1021/acs.jmedchem.3c01514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.11.2023. Verfasst von Simon R Green und 22 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Benzofurans. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an urgent need for new tuberculosis (TB) treatments, with novel modes of action, to reduce the incidence/mortality of TB and to combat resistance to current treatments. Through both chemical and genetic methodologies, polyketide synthase 13 (Pks13) has been validated as essential for mycobacterial survival and as an attractive target for Mycobacterium tuberculosis growth inhibitors. A benzofuran series of inhibitors that targeted the Pks13 thioesterase domain, failed to progress to preclinical development due to concerns over cardiotoxicity. Herein, we report the identification of a novel oxadiazole series of Pks13 inhibitors, derived from a high-throughput screening hit and structure-guided optimization. This new series binds in the Pks13 thioesterase domain, with a distinct binding mode compared to the benzofuran series. Through iterative rounds of design, assisted by structural information, lead compounds were identified with improved antitubercular potencies (MIC < 1 μM) and in vitro ADMET profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisBenzofuransPolyketide SynthasesAntitubercular AgentsMicrobial Sensitivity Tests

Substanzen

Polyketide SynthasesAntitubercular AgentsBenzofurans

Autor:innen und Institutionen

  • Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
  • Global Health Medicines R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid Spain.
  • Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States.
  • Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.
  • Structural Genomics Consortium, Research Institute of the McGill University Health Centre, 1001 Boulevard Décarie, Site Glen Block E, ES1.1614, Montréal, QC H4A 3J1, Canada.

ORCID-Profile: Simon R Green, Nicola Caldwell, Barbara Forte, Helena I M Boshoff, Ian H Gilbert, Kevin D Read, Paul G Wyatt, Beatriz Baragaña

Förderung

  • Wellcome Trust
  • Bill and Melinda Gates Foundation

Zitieren

APA

Green, S. R., Wilson, C., Eadsforth, T. C., Punekar, A. S., Tamaki, F. K., Wood, G., Caldwell, N., Forte, B., Norcross, N. R., Kiczun, M., Post, J. M., Lopez-Román, E. M., Engelhart, C. A., Lukac, I., Zuccotto, F., Epemolu, O., Boshoff, H. I. M., Schnappinger, D., Walpole, C., …, & Baragaña, B. (2023). Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity. Journal of Medicinal Chemistry, 66(22), 15380-15408. https://doi.org/10.1021/acs.jmedchem.3c01514

Vancouver

Green SR, Wilson C, Eadsforth TC, Punekar AS, Tamaki FK, Wood G, et al. Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity. Journal of Medicinal Chemistry. 2023;66(22):15380-15408. doi:10.1021/acs.jmedchem.3c01514

BibTeX
@article{Green2023,
  author = {Green, Simon R and Wilson, Caroline and Eadsforth, Thomas C and Punekar, Avinash S and Tamaki, Fabio K and Wood, Gavin and Caldwell, Nicola and Forte, Barbara and Norcross, Neil R and Kiczun, Michael and Post, John M and Lopez-Román, Eva Maria and Engelhart, Curtis A and Lukac, Iva and Zuccotto, Fabio and Epemolu, Ola and Boshoff, Helena I M and Schnappinger, Dirk and Walpole, Chris and Gilbert, Ian H and Read, Kevin D and Wyatt, Paul G and Baragaña, Beatriz},
  title = {Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {22},
  pages = {15380--15408},
  doi = {10.1021/acs.jmedchem.3c01514}
}
Kostenlos starten →